A RANDOMIZED, OPEN LABEL STUDY TO COMPARE THE EFFICACY AND SAFETY OF VILDAGLIPTIN AND METFORMIN COMBINATION VERSUS VILDAGLIPTIN ALONE IN TYPE 2 DIABETES MELLITUS PATIENTS IN A TERTIARY CARE HOSPITAL.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.